Page 9 - Pfizer

Two Sputnik doses provide two times higher antibodies than Pfizer: Study

A study has found that two doses of Sputnik V provide two times higher virus neutralising antibodies against the Omicron variant of COVID-19 than two doses of the Pfizer vaccine

FDA may authorise Pfizer's Covid vax for kids under 5 in Feb: Fauci

The US Food and Drug Administration (FDA) is likely to approve Pfizer's Covid vaccine for children under 5 years of age in February, White House chief medical advisor Anthony Fauci has said.

Hyderabad's Biophore to manufacture ingredients of Pfizer's Covid drug

Biophore India Pharmaceutical announced that it developed and started manufacturing the key intermediates of Nirmatrelvir, one of the active ingredients of Paxlovid, the latest anti-Covid therapy

Pfizer chief Albert Bourla wins $1 mn Genesis Prize for vaccine development

Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded the prestigious Genesis Prize for his efforts in leading the development of a Covid-19 vaccine

South Korea gets first supply of Pfizer's antiviral Covid-19 pills

Health officials have described the Paxlovid pills as a potentially important tool to suppress hospitalisations and deaths

What are the new Covid-19 vaccine platforms?

Rising cases of Covid-19 have unsettled the government. It recently approved two new vaccines. But, what is the difference between these vaccines? What platforms are used to develop them? Find out

South Korea authorises Novavax Covid-19 vaccine, imports Pfizer pills

At least 21,000 of Pfizer's antiviral pills, called Paxlovid, will arrive in South Korea on Thursday, with another 10,000 more expected to arrive by the end of the month, the health ministry said

Pfizer's Omicron specific vaccine to be ready by March, says CEO

Pfizer's vaccine that specifically targets the Omicron variant of Covid-19 will be ready in March, the pharmaceutical giant's CEO Albert Bourla has said

Omicron spread: Pfizer seeks conditional EU authorisation for Covid-19 pill

The announcement comes as countries in much of the 27-nation bloc are reporting soaring numbers of infections

US CDC recommends Pfizer's Covid vaccine booster dose for ages 12 to 15

The US's CDC said it expanded the eligibility of Pfizer Inc and BioNTech SE's booster doses to those 12 to 15 years old

BioNTech, Pfizer plan shingles shot in third joint mRNA project

The partners expect to start human trials of the new vaccine in the second half of this year, they said in a statement

Covid-19: US to double order of Pfizer treatment courses, says Biden

To decrease hospitalisations and deaths from Covid, the US administration is going to double its order of Pfizer treatment courses, President Joe Biden said

US FDA authorises Pfizer-BioNTech booster shots for kids aged 12-15

The US FDA has expanded the emergency use authorisation for the Pfizer-BioNTech Covid-19 vaccine boosters to children aged 12 to 15.

Covid: FDA expands Pfizer boosters for more teens as omicron surges

The US is expanding Covid-19 boosters as it confronts the omicron surge, with the Food and Drug Administration allowing extra Pfizer shots for children as young as 12.

Why are mRNA vaccines effective against severe coronavirus infection?

A team of US researchers has explored the success behind the new mRNA vaccine technology used by Pfizer and Moderna to make vaccines against Covid.

South Korea approves emergency authorisation of Pfizer's oral Covid pill

South Korea on Monday approved an emergency authorization of US drug giant Pfizer Inc.'s oral drug to treat Covid-19, making it the first such pill to be used in the country.

US donates 5 million doses of Pfizer coronavirus vaccine to Pakistan

The United States has announced shipping an additional five million doses of Pfizer's coronavirus vaccine to Pakistan through the COVAX facility.

United States donates 664,560 doses of Pfizer vaccines to Nepal

The United States has donated 664,560 new doses of Pfizer vaccine to Nepal to help it intensify its fight against the coronavirus, the US Embassy said here on Friday. The new doses of Pfizer vaccine given to Nepal free of cost is in addition to the doses the US had provided early this year when the cases of coronavirus were constantly on a rise. "The US government has donated an additional 664,560 doses of Pfizer vaccine to Nepal government to fight COVID-19. These highly effective life-saving vaccines for ages 12 and older add to the 100,620 doses of Pfizer vaccines and 1.535 million single-dose Johnson & Johnson vaccines the United States gifted to Nepal earlier this year," the US Embassy in Kathmandu said in a statement. This support augments the more than USD 122 million in assistance provided (excluding including vaccine costs) to Nepal to-date in the form of life-saving medical supplies, training, and technical support, the statement added. The US said it is donating ...

Pfizer's Covid pill will take about 6-8 months to come to US markets

While the US FDA has approved Pfizer antiviral pill to treat Covid-19, the White House has warned that the drug will not be available in the markets before six-eight months.

US FDA authorizes Pfizer's Covid-19 antiviral pill for people aged 12

The US Food and Drug Administration (FDA) on Wednesday (local time) authorized Pfizer's Paxlovid COVID-19 pill for high-risk people aged 12 and over to treat coronavirus disease (COVID-19)."The US Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer's Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death," US Food and Drug said in a statement."Today's authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally -- a major step forward in the fight against this global pandemic," said Patrizia Cavazzoni, M.D., director of the FDA's Center for Drug Evaluation and